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In the course of studies on the ultrastructural lo- 
calization and functions of contractile proteins in 
nonmuscle cells, we have found it useful to adapt 
the avidin-biotin complex technique introduced by 
Heitzmann and Richards (7) to the specific label- 
ing of actin and myosin components in these cells. 
These  authors modified cell surfaces by covalent 
attachment of biotinyl residues,  and then visual- 
ized  these  residues  in  electron  microscopy  by 
staining with a  ferritin-avidin conjugate, thereby 
making  use  of  the  extraordinarily  high  binding 
affinity of biotin for avidin (5). We have used this 
general procedure to develop two specific fluores- 
cence  staining  procedures,  one  for  intracellular 
actin, the other for myosin. The actin procedure 
involves  the  successive  reaction  with  biotin-la- 
beled heavy meromyosin (HMM) followed by flu- 
orescein-labeled avidin, which  in our hands  has 
given results superior to those obtained with the 
use  of  direct  fluorescein-labeled  HMM  as  de- 
scribed by Sanger (11). The myosin labeling pro- 
cedure  involves the  successive reaction with bio- 
tin-labeled antimyosin antibody followed by fluo- 
rescein-labeled avidin, which provides an alterna- 
tive and comparably effective staining procedure 
to  the  usual  indirect  immunofluorescence tech- 
nique. 
MATERIALS  AND  METHODS 
Muscle Proteins 
Actin was purified from acetone powders  of rabbit 
back muscle by the method of Spudich and Watt (14). 
HMM was prepared from rabbit skeletal muscle myosin 
(15) by a limited tryptic digestion as described by Lowey 
et al. (10). These proteins were stored in 50% glycerol at 
-20~  Rabbit myofibrils were prepared by the proce- 
dure of Zak et ai. (18). 
Biotinyl-N-Hydroxysuccinimide 
Ester ( BOSu) 
This reagent was synthesized by the method of Heitz- 
mann and Richards (7), and was stored over dessicant at 
4~  It  was  found to  be  stable  for  at  least  12  mo. 
Radioactive  BOSu (6.4 ￿  104 cpm/~mol) was prepared 
by adding [~4C]biotin  (Amersham/Searle Corp., Arling- 
ton Heights, I11.) to the biotin used for the synthesis. 
Biotin-Labeled  HMM 
4 mg of fibrous actin and 4 mg of HMM were dialyzed 
separately overnight against  0.15  M  KC1  in 0.01  M 
potassium phosphate  buffer, pH 7.5  (PBK). The two 
protein solutions were combined, so as to protect  the 
actin-binding  site of HMM during the chemical modifica- 
tion (11). The volume was adjusted to 7.5 ml with PBK, 
and this solution was brought to room temperature. The 
pH of the protein solution was then raised to 8.8 by the 
addition of 2.5 ml of a buffer containing  0.2 M NaHCO.~ 
and 0.15 M KCI, pH 8.8. The reaction was initiated by 
adding 5 ~1 (preparation A) or 8/~1 (preparation B) of a 
freshly  prepared  solution of BOSu  (12  mg/ml) in di- 
methylformamide. The solution was mixed gently and al- 
lowed to react for 5 rain with periodic gentle stirring. The 
reaction was then quenched by the addition of 50 pl of 1 
M NH4CI (pH 6). The modified acto-HMM was pelleted 
by centrifugation for 1 h at 180,000 g. This pellet was 
recovered, suspended in 2 ml of PBK containing sodium 
pyrophosphate (0.01 M) and MgCI~ (0.002 M) (to disso- 
ciate the actin-HMM bond), and homogenized with four 
strokes in a glass homogenizer. This solution was then 
centrifuged for 1 h at 180,000 g  to sediment the actin 
into a  pellet. The supernate, containing the  modified 
HMM (BHMM) product, was dialyzed against at least 
three l-liter volumes of PBK. 
Biotin-Labeled  Antibody 
The preparation of rabbit anti-human uterine myosin 
IgG has been described previously (12). A 0.4-ml solu- 
tion of the IgG fraction (6.3 mg/ml) in PBK was mixed 
with 0.1 ml of 0.2 M NaHCO3 in 0.15 M KCI (pH 8.8) 
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ing 5/zl of a 12 mg/ml solution of BOSu in dimethylfor- 
mamide with gentle mixing at room temperature. After 
10 min the reaction was quenched by the addition of 50 
/zl of 1 M NH4CI and the product dialyzed for at least 3 
days against several changes of PBK. 
Fluorescein  Labeled A vidin 
( FI-Avidin ) 
4.5 mg of avidin (Sigma Chemical Co., Saint Louis, 
Mo.)  was dissolved in 0.9 ml of PBK, and to this was 
added 0.4 ml of 0.2 M  NaHCO.~  in 0.15  M NaCI (pH 
8.8). Fluorescein isothiocyanate on Celite (4 mg of 8% 
powder,  Calbiochem, San Diego,  Calif.) was added in 
suspension, and the mixture was incubated at room tem- 
perature with constant stirring for 10 rain. The reaction 
was  then quenched by the addition of 200  /zl  of  1 M 
NH4CI (pH 6.0), the Celite was removed by centrifuga- 
tion, and the Fl-avidin solution was dialyzed for 2 days 
against several changes of PBK to remove free dye. The 
Fl-avidin was stored with 0.02% sodium azide at 4~  and 
was stable for at least 3 mo. 
Cell Culture 
The cell line WI 38 was obtained from the American 
Type  Culture  Collection .(Rockville,  Md.).  The  NRK 
cells were provided by Dr.  Peter Vogt.  All cells were 
cultured in  Dulbecco's modified Eagle's Medium con- 
taining 10%  fetal calf serum  and antibiotics under an 
atmosphere of 10% CO~-90% air. 
Fluorescence  Staining  of Cells 
Cells were plated onto glass cover slips at low densities 
and cultured for at least 1 day before use.  Cells were 
fixed with 2% formaldehyde in PBK for 20 min at room 
temperature. After fixation they were rinsed with three 
10-min changes of PBK, the second change containing 
10 mM NH,CI. The cells were then made permeable to 
proteins by  freezing and  thawing them  once  (2).  For 
actin localization the cells were  then incubated with a 
BHMM solution (in PBK) in the concentration range of 
0.05-0.2  mg/ml for 20 min at room temperature. For 
myosin localization the biotinyl antimyosin IgG at 2-3 
mg/ml was used for 20 min. In either case, the cells were 
then rinsed with four changes of PBK for a total of 20 
min to wash out the unbound biotinyl protein and then 
incubated for 20 min in 0.06 mg/ml FI-avidin in PBK. 
After a final wash with PBK for 20 min the cover slips 
were inverted on a drop of 90% glycerol-10% PBK. The 
cells were observed and photographed on a  Zeiss pho- 
tomicroscope, using either a dark field condenser or epi- 
illumination. 
Other Methods 
The  actin-activated ATPase  activity of the modified 
(prep. A) and unmodified HMM was measured by the 
method of Spudich (13). The EDTA-stimulated ATPase 
activities were measured by this assay as modified by Ash 
(1).  Protein  concentrations  were  determined  by  the 
method of Lowry et al. (9) as modified by Hartree (6). 
Polyacrylamide  gel  electrophoresis on  4%  gels  in  the 
presence of 0.2%  sodium  dodecyl  sulfate was  accom- 
plished by the method of Fairbanks et al. (3). 
RESULTS 
BHMM 
Figure  1  shows a  sodium  dodecyl  sulfate-poly- 
acrylamide  gel  electrophoretic  analysis  of HMM 
before  and  after  modification  with  biotin.  The 
t]HMM is free of actin contamination as analyzed 
by this technique.  The  degree  of biotin substitu- 
tion of two different preparations of BHMM  and 
their stoichiometry  of  binding with  Fl-avidin are 
summarized in Table I. As demonstrated in Table 
I,  the  modification  of HMM  does  not impair  its 
actin  binding  activity.  By  measuring  the  molar 
ratio of fluorescein to BHMM in an acto-BHMM- 
Fl-avidin  complex  rather  than  in  a  BHMM-Fl- 
avidin complex, we hoped to obtain a  more accu- 
rate estimate of the binding ratio that would result 
when staining fibrous actin in situ. 
FIGURE  1  Polyacrylamide  gel  electrophoresis on  4% 
gels in the presence of sodium dodecyl sulfate of:  (a) 
rabbit HMM, (b) BHMM (prep. A), and (c) actin. 
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Stoichiometry of F1-Avidin-BHMM Complex 
P~p.A*  P~p.B 
No.  of  biotin  molecules per  8.5  12 
HMM molecule~: 
No. of avidin molecules bound  4.5  7.2 
by each HMM moleculew 
Molar  ratio  of  fluorescein  to  13.2  20 
BHMM in the acto-BHMM- 
Fl-avidin complex  u 
* See Materials and Methods. 
$ Determined by using radioactive biotin. 
w  A 1-ml solution containing 0.2 mg of BHMM and 0.2 
mg of actin in PBK was added to 1 ml of PBK containing 
0.4 mg of Fl-avidin. The acto-BHMM-Fl-avidin com- 
plex was centrifuged into a pellet, and the amount of F1- 
avidin removed from the solution was determined from 
the reduction in absorbance at 495 nm (the absorption 
maximum of fluorescein bound to protein) of the super- 
hate, All of the BHMM was removed with the actin as 
determined by three criteria: (a) the A4~/A2ao ratio of 
the  supernatant  fraction was  identical to  that  of  F1- 
avidin alone, (b) no detectable [14C]biotin  radioactivity 
remained  in the  supernate,  and  (c)  no BHMM was 
detected by gel electrophoretic analysis of the superna- 
tant fraction. When this experiment was performed in 
the presence of biotin (0.02 mg/ml), less than 4% of the 
Fl-avidin  was removed by centrifugation, although all of 
the BHMM was pelleted with the actin. 
1, The Fl-avidin had an A4~/A28o ratio of 1.2. From the 
extinction coefficient of fluorescein (4) and the protein 
concentration, it was determined that an average of 2.9 
fluorescein molecules were bound to each avidin mole- 
cule. 
The  actin-activated  ATPase  activities  of 
BHMM  (prep.  A) and the  HMM from which it 
was  made  were  identical. The high-salt EDTA- 
stimulated ATPase  activity of  this  BHMM  was 
0.42  p~mol Pi/min/mg protein compared to 0.52 
/xmol  Pi/min/mg  protein  for  the  unmodified 
HMM. These results suggest that the  active site 
of the HMM was not seriously affected by modifi- 
cation with biotin under the protective conditions 
used. 
Cells stained with BHMM and Fl-avidin showed 
an array of clear and distinct filaments (Figs. 2 and 
3). In many cases, these fluorescent filaments cor- 
responded to the stress fibers seen with Nomarski 
differential contrast optics (Fig. 3). Also, as seen 
in Fig. 3, there was intense staining near the edges 
of cells in areas of ruffled membrane activity. 
Cells stained in the presence of magnesium and 
pyrophosphate (see Fig. 2b), which prevents the 
binding  of HMM to actin, were only dimly fluores- 
cent.  There  were  no filaments visible, although 
there was some staining of the cytoplasm and of 
small bodies within the  nucleus. Similarly, only 
this dim background staining was observed if the 
Fl-avidin was  presaturated  with free  biotin (0.1 
mg/ml) to prevent its binding to the BHMM (Fig. 
2c).  Cells treated  with  Fl-avidin alone, without 
pretreatment with BHMM, had this same appear- 
ance, although, in cells undergoing mitosis, the FI- 
avidin was found to bind to the condensed chro- 
mosomes. This observation will be reported else- 
whereJ This low level staining with Fi-avidin can 
be eliminated by competition with unmodified avi- 
din. 
Myofibrils stained with  BHMM  and Fl-avidin 
showed intense staining of the 1-band region with 
the Z-band region clearly unstained (Figure 2 e). 
Myofibrils were  not  stained if the  BHMM  was 
added  in the  presence  of magnesium and pyro- 
phosphate. 
Biotinyl Antibodies 
Table II summarizes the degree of biotin substi- 
tution and FI-avidin binding properties of the bio- 
tinyl IgG. The molar binding ratios shown in Ta- 
ble II were derived from a precipitated complex of 
biotinyl IgG and Fl-avidin. They may underesti- 
mate  the  ratios  which  occur  in  the  fluorescent 
staining of cells.  Cells stained with  the  biotinyl 
antimyosin antibody showed  bright  filamentous 
staining (Fig.  4).  Presaturation of  the  Fl-avidin 
with free biotin prevented this specific staining. 
DISCUSSION 
The results of experiments with the  BHMM-FI- 
avidin reagents for actin localization are compara- 
ble  to  those  obtained by  Lazarides  and  Weber 
using a fluorescent-labeled antibody to actin (8). 
Our method for the localization of actin by means 
of HMM has two new features: (a) fixation of the 
cells before staining which most likely preserves 
structure  more  adequately than  glycerol extrac- 
tion, and (b) the amplification of the fluorescence 
afforded by this indirect method. 
The  results with  the  biotinyl antimyosin anti- 
bodies and FI-avidin were indistinguishable from 
those obtained with indirect immunofluorescence 
(16,  17).  These results demonstrate the  general 
usefulness of the avidin-biotin  complex for locali- 
zation with the fluorescence microscope, and they 
provide an alternative to the use of a second anti- 
body for the amplification of the fluorescent sig- 
' Heggeness, M. H. 1977. Manuscript in preparation. 
BRIEF NOTES  785 FIGURE  2  Examples of BHMM-Fl-avidin staining for actin and controls. (a) An NRK cell stained with 
BHMM  and  FI-avidin  to  localize  actin.  In  Fig.  2b-d  NRK  cells  are  stained  under  various  control 
conditions,  photographed  and  printed  as  in  Fig.  2a.  The  cytoplasm  adjacent  to  the  nucleus,  which 
contained  the  only  detectable  staining,  is  shown.  (b)  An  NRK  cell  stained  in  the  presence  of 
sodium pyrophosphate (0.005 M) and magnesium chloride (0.002 M) to prevent the binding of BHMM to 
the cellular actin. (c) An NRK cell stained in the presence of biotin (0.1 mg/ml) to prevent the binding of 
Fl-avidin to the BHMM. (d) An NRK cell stained with BHMM and FI-avidin after preincubation with 
unmodified HMM.  (e) A  rabbit skeletal muscle myofibril stained for actin. Bars,  I0/~m. 
FIGURE  3  An NRK cell stained for actin with BHMM and Fl-avidin (a) Image obtained with Nomarski 
optics. (b) Fluorescence image. Arrows indicate regions of ruffled membrane activity. Bars, 10/~m. FIGURE 4  A  W138 cell stained for myosin by using Biotinyl antimyosin and FI-avidin. Bar, 10 p.m. 
TABLE  II 
Stoichiometry of F1-A vidin Biotinyl IgG Complex 
Exp 1  Exp 2 
No. of biotin molecules per IgG  7.8  7.8 
molecule* 
No. of avidin molecules bound  3.8  4.0 
by each IgG moleculer 
Molar  ratio  of  fluorescein  to  11.1  11.7 
IgG in complex~t 
* Determined by using radioactive biotin. 
~: 25 /xl of biotinyl antimyosin IgG (4.5  mg/ml in PBK) 
was added to 1.0 ml of a 0.4 mg/ml solution of Fl-avidin 
in PBK. As measured by the radioactive biotin, 79% of 
the biotinyl IgG was precipitated by the Fl-avidin after 
45 rain at 0~  The amount of Fl-avidin in this precipi- 
tate  was  calculated from the amount of fluorescein re- 
moved from the solution,  as  assayed by the change in 
absorbance  at 495  nm.  When this experiment was per- 
formed in the presence of biotin (0.02 mg/ml), no pre- 
cipitation was observed. 
nal.  The  simultaneous  cellular localization of ac- 
tin, using BHMM and Fl-avidin, and another pro- 
tein  using  standard  indirect  immunofluorescence 
with a rhodamine-conjugated antibody, should be 
possible  since  the  two  sets  of  reagents  do  not 
interact. Such experiments are now in progress. 
SUMMARY 
A  new indirect  method  for fluorescence localiza- 
tion  of proteins  making  use  of the  avidin-biotin 
complex is  described.  We  have  prepared  both  a 
biotin-modified  rabbit  heavy  meromyosin 
(BHMM)  and  a  biotin-modified  antibody  to  a 
smooth muscle myosin. After fixation, cells can be 
treated with either BHMM, which binds to actin, 
or the biotinyl antibody, which binds to myosin. In 
a  second step the cells are treated with a  fluores- 
cent derivative of avidin (Fl-avidin) which binds to 
the biotinyl proteins and thus indirectly reveals the 
location of the cellular actin or myosin. 
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